| Dr Kaleel James Shaheen, OD | |
|
4555 Hills And Dales Rd Nw, Canton, OH 44708-1507 | |
| (330) 478-8996 | |
| (330) 478-9987 |
| Full Name | Dr Kaleel James Shaheen |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 52 Years |
| Location | 4555 Hills And Dales Rd Nw, Canton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215932652 | NPI | - | NPPES |
| 0197675 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3044T647 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hills And Dales Vision Inc | 6709919178 | 3 |
News Archive
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
Rosie Zaballos liked to host playtime tea parties and was sweet to everyone she met. But her older brother worried that the 16-year-old, whom her family described as "a little slow," might someday become pregnant.
Forget the drastic reduction in carbs and calories called for by diet dictators. The day when people can eat their favorite foods, stay thin and live to be 120 without getting age-induced diabetes or cancer may be nearer than we think.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Provider Name | Hills & Dales Vision Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356547889 PECOS PAC ID: 6709919178 Enrollment ID: O20100805000494 |
News Archive
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
Rosie Zaballos liked to host playtime tea parties and was sweet to everyone she met. But her older brother worried that the 16-year-old, whom her family described as "a little slow," might someday become pregnant.
Forget the drastic reduction in carbs and calories called for by diet dictators. The day when people can eat their favorite foods, stay thin and live to be 120 without getting age-induced diabetes or cancer may be nearer than we think.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kaleel James Shaheen, OD 4555 Hills And Dales Rd Nw, Canton, OH 44708-1507 Ph: (330) 478-8996 | Dr Kaleel James Shaheen, OD 4555 Hills And Dales Rd Nw, Canton, OH 44708-1507 Ph: (330) 478-8996 |
News Archive
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
Rosie Zaballos liked to host playtime tea parties and was sweet to everyone she met. But her older brother worried that the 16-year-old, whom her family described as "a little slow," might someday become pregnant.
Forget the drastic reduction in carbs and calories called for by diet dictators. The day when people can eat their favorite foods, stay thin and live to be 120 without getting age-induced diabetes or cancer may be nearer than we think.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
Dr. Brian M Mathie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5890 Mayfair Rd, Canton, OH 44720 Phone: 330-305-2200 Fax: 330-305-2210 | |
Charles E Belles, OD OPTOMETRIST Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4571 Everhard Rd Nw, Canton, OH 44718 Phone: 330-494-5020 Fax: 330-494-0004 | |
Dr. John J Devito Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 3703 Cleveland Ave Nw, Canton, OH 44709 Phone: 330-493-9803 Fax: 330-493-9804 | |
Nathaniel James Leggett, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4822 Cleveland Ave S, Canton, OH 44707 Phone: 330-484-2569 Fax: 330-236-8188 | |
Dr. Kristi K. Stalker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2600 Tuscarawas St W, Suite 200, Canton, OH 44708 Phone: 330-456-0047 Fax: 330-456-9308 | |
Accent On Eyes Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3730 Whipple Ave Nw, Suite 100, Canton, OH 44718 Phone: 330-493-3013 Fax: 330-493-3110 |